Rheumatology International

, Volume 29, Issue 12, pp 1529–1530

Early onset neutropenia after mycophenolate mofetil in systemic sclerosis

  • Giovanna Cuomo
  • Giuseppina Abignano
  • Gabriele Valentini
Letter to the Editors


  1. 1.
    Ciancio G, Miller J, Gonwa TA (2005) Review of major clinical trial with mycophenolate mofetil in renal transplantation. Transplantation 80 (2 Suppl):S191–S200. doi:10.1097/01.tp.0000187035.22298.ba PubMedCrossRefGoogle Scholar
  2. 2.
    Kobashigawa JA, Meiser BM (2005) Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 80 (2 Suppl):S235–S243. doi:10.1097/01.tp.0000186383.22264.b3 PubMedCrossRefGoogle Scholar
  3. 3.
    Chan TM, Li FK, Tang CS et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156–1162. doi:10.1056/NEJM200010193431604 PubMedCrossRefGoogle Scholar
  4. 4.
    Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219–2228. doi:10.1056/NEJMoa043731 PubMedCrossRefGoogle Scholar
  5. 5.
    Shimizu H, Takahashi M, Takeda S et al (2004) Mycophenolate mofetil prevents transplant ateriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 77:1661–1667. doi:10.1097/01.TP.0000127592.13707.B6 PubMedCrossRefGoogle Scholar
  6. 6.
    Miljkovic DJ, Cvetkovic I (2003) STOSIC-GRUJICIC, TRAJKOVIC V: mycophenolate acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts. Clin Exp Immunol 132:239–246. doi:10.1046/j.1365-2249.2003.02140.x PubMedCrossRefGoogle Scholar
  7. 7.
    Liossis SN, Bounas A, Andonopoulos AP (2006) Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. Rheumatology 45:1005–1008. doi:10.1093/rheumatology/kei211 PubMedCrossRefGoogle Scholar
  8. 8.
    Nihtyanova SI, Brough GM, Black CM, Denton CP (2007) Mycophenolate mofetil in diffuse cutaneous systemic sclerosis—a retrospective analysis. Rheumatology 46:442–445. doi:10.1093/rheumatology/kel244 PubMedCrossRefGoogle Scholar
  9. 9.
    Vanthuyne M, Blockmans D, Westhovens R et al (2007) A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol 25:287–292PubMedGoogle Scholar
  10. 10.
    Nogueras F, Espinosa MD, Mansilia A et al (2005) Mycophenolate mofetil-induce neutropania in liver transplantation. Transplant Proc 37:1509–1511. doi:10.1016/j.transproceed.2005.02.038 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Giovanna Cuomo
    • 1
  • Giuseppina Abignano
    • 1
  • Gabriele Valentini
    • 1
  1. 1.Rheumatology UnitSecond University of NaplesNaplesItaly

Personalised recommendations